•  
  •  
  •  
 

RNA Leaders

We focus on developing novel RNA-centered approaches to addressing unmet medical needs. SomaGenics' research and development has been supported by over $20M in competitive grants and it is our policy to publish the results of our efforts in respected peer-reviewed journals. Our staff includes internationally recognized leaders in RNA research and technology development. Learn more...

more about SomaGenics

Latest from SomaGenics

 

SomaGenics Granted New Patents for RNA Detection and RNA-based Therapeutics Technologies

SANTA CRUZ, Calif. November 2016 – SomaGenics, an RNA-focused biotechnology company, announced expansion of its intellectual property portfolio with issue of two new patents for its RNA analysis technologies (miR-ID®...

Read more

SomaGenics secures $1.8M in funding from NIH to further develop the Real-Seq® technology platform

SANTA CRUZ, Calif. October 2016 – SomaGenics has been awarded a $1.8M two-year NIH SBIR Phase II grant to further develop its RealSeq®–AC technology for next-generation sequencing (NGS) of small...

Read more

SomaGenics to present at the 12th annual Oligonucleotide Therapeutics Society (OTS) meeting

September, 2016  SomaGenics will present recent progress in its RNA detection and sshRNA therapeutics programs in two posters at the OTS Annual Meeting in Montreal, Quebec, September 25-28, 2016.

Read more

SomaGenics to present at the 7th non-coding RNA & RNAi Therapeutics conference, Boston, MA on September 14, 2016

Santa Cruz, Calif. September 14, 2016  SomaGenics will present at the 7th non-coding RNA & RNAi Therapeutics conference by Global Technology Community on September 14 in Boston, MA. Dr. Johnston...

Read more

Rubicon Genomics Licenses Commercialization Rights from SomaGenics for Its RealSeq®-AC Technology for High-Throughput Sequencing of Small RNAs

Santa Cruz, Calif. July 28, 2016 SomaGenics Inc. today announced that it has signed a licensing agreement with Rubicon Genomics, Inc. for commercialization of SomaGenics’ RealSeq®-AC library preparation technology for sequencing...

Read more

SomaGenics is a privately held biotech company with offices and laboratories located in Santa Cruz, CA. We specialize in small RNA technologies, including innovative RNAi-based therapeutics using sshRNA molecules, and diagnostics/biomarker detection of small or fragmented RNA, including microRNAs.

learn more